A Pragmatic, Randomized Controlled Trial of Oral Antivirals for the Treatment of Chronic Hepatitis C: The PRIORITIZE Study-Reference-Cited by-同舟云学术

A Pragmatic, Randomized Controlled Trial of Oral Antivirals for the Treatment of Chronic Hepatitis C: The PRIORITIZE Study

Published:2021-08-26 Issue:6 Volume:74 Page:2952-2964
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Sulkowski Mark S.¹^ORCID,Moon Juhi S.¹,Sherman Kenneth E.²^ORCID,Morelli Giuseppe³,Darling Jama M.⁴,Muir Andrew J.⁵^ORCID,Khalili Mandana⁶^ORCID,Fishbein Dawn A.⁷,Hinestrosa Federico⁸,Shiffman Mitchell L.⁹,Di Bisceglie Adrian¹⁰,Rajender Reddy K.¹¹,Pearlman Brian¹²,Lok Anna S.¹³,Fried Michael W.⁴,Stewart Paul W.¹⁴,Peter Joy³,Wadsworth Summer¹⁵,Kixmiller Scott¹⁶,Sloan Anquenette¹⁷,Vainorius Monika⁴,Horne Patrick M.³,Michael Larry¹⁴,Dong Meichen¹⁴,Evon Donna M.⁴,Segal Jodi B.¹⁸,Nelson David R.³,

Affiliation:

1. Division of Infectious Diseases Johns Hopkins University School of Medicine Baltimore MD

2. Department of Internal Medicine University of Cincinnati College of Medicine Cincinnati OH

3. Department of Gastroenterology, Hepatology & Nutrition University of Florida Gainesville FL

4. Division of Gastroenterology and Hepatology University of North Carolina at Chapel Hill Chapel Hill NC

5. Division of Gastroenterology Duke University Durham NC

6. Department of Medicine University of California San FranciscoZuckerberg San Francisco General, Hospital and Trauma Center San Francisco CA

7. Infectious Disease Medstar Health Research Institute Washington DC

8. Infectious Disease Orlando Immunology Center Orlando FL

9. Department of Gastroenterology Liver Institute of Virginia Richmond VA

10. Department of Internal Medicine Saint Louis University School of Medicine St. Louis MO

11. Department of Medicine University of Pennsylvania Philadelphia PA

12. Department of Internal Medicine Wellstar Health System Atlanta GA

13. Department of Internal Medicine University of Michigan Ann Arbor MI

14. Department of Biostatistics University of North Carolina at Chapel Hill, Chapel Hill, NC

15. PRIORITIZE Patient Engagement Group consultant Garner, NC

16. PRIORITIZE Patient Engagement Group consultant Greensboro, NC

17. PRIORITIZE Patient Engagement Group consultant Pittsboro, NC

18. Division of Internal Medicne Johns Hopkins University School of Medicine Baltimore MD

Funder

Patient-Centered Outcomes Research Institute

AbbVie

Merck

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.32053

Reference31 articles.

1. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study;Polaris Observatory HCV Collaborators;Lancet Gastroenterol Hepatol,2015

2. Cure With Interferon‐Free Direct‐Acting Antiviral Is Associated With Increased Survival in Patients With Hepatitis C Virus‐Related Hepatocellular Carcinoma From Both East and West

3. Estimating Prevalence of Hepatitis C Virus Infection in the United States, 2013-2016

4. AASLD/IDSA HCV Guidance PanelRecommendations for testing managing and treating hepatitis C website. Published 2017. Accessed June 13 2017.http://hcvguidelines.org

5. Public–Private Partnership: Targeting Real-World Data for Hepatitis C Direct-Acting Antivirals

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revolutionizing HCV Therapy: microRNA Approaches in New Era of Treatment;Liver Cancer - Multidisciplinary Approach;2024-07-11

2. A 10-Year Retrospective Cohort Study of Real-World Effectiveness of Sofosbuvir-Based Regimens for Hepatitis C in a Single Center in China;Infectious Microbes and Diseases;2023-10-24

3. Hepatitis C Virus: Insights Into Its History, Treatment, Challenges, and Future Directions;Cureus;2023-08-22

4. Clinical trials reimagined;Hepatology;2023-05-05

5. Long-term Follow-up of Hepatitis C Patients Who Achieved Sustained Virologic Response in the Pragmatic PRIORITIZE Study;Clinical Gastroenterology and Hepatology;2023-02